Carolina Mendonça Gorgulho

Carolina Mendonça Gorgulho

Auto-generated profile, based on publicly available information

Carolina Mendonça Gorgulho

Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (Unesp), Botucatu, São Paulo

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
CGCarolina M. Gorgulho
Carolina M. Gorgulho
GRGraziela G. Romagnoli
Graziela G. Romagnoli
RBRosh Bharthi
Rosh Bharthi
MLMichael Thomas Lotze
Michael Thomas Lotze
Although much has been made of the role of HMGB1 acting as an acute damage associated molecular pattern (DAMP) molecule, prompting the response to tissue damage or injury, it is also released at sites of chronic inflammation including sites of infection, autoimmunity, and cancer. As such, the biology is distinguished from homeostasis and acute inflammation by the recruitment and persistence of myeloid derived suppressor cells, T regulatory cells, fibrosis and/or exuberant angiogenesis depending on the antecedents and the other individual inflammatory partners that HMGB1 binds and focuses, including IL-1β, CXCL12/SDF1, LPS, DNA, RNA, and sRAGE. High levels of HMGB1 released into the extracellular milieu and its persistence in the microenvironment can contribute to the pathogenesis of many if not all autoimmune disorders and is a key factor that drives inflammation further and worsens symptoms. HMGB1 is also pivotal in the maintenance of chronic inflammation and a "wound healing" type of immune response that ultimately contributes to the onset of carcinogenesis and tumor progression. Exosomes carrying HMGB1 and other instructive molecules are released and shape the response of various cells in the chronic inflammatory environment. Understanding the defining roles of REDOX, DAMPs and PAMPs, and the host response in chronic inflammation requires an alternative means for positing HMGB1's central role in limiting and focusing inflammation, distinguishing chronic from acute inflammation.

14 January 2020 in Materials
Verified
Journal Article
Open access
PDF file
RLRaquel B. Liszbinski
Raquel B. Liszbinski
GCGraziela Gorete Romagnoli Castilho
Graziela Gorete Romagnoli Castilho
CGCarolina M. Gorgulho
Carolina M. Gorgulho
CBCaroline Rodrigues Basso
Caroline Rodrigues Basso
Valber de Albuquerque PedrosaValber de Albuquerque Pedrosa
Valber de Albuquerque Pedrosa
RKRamon Kaneno
Ramon Kaneno
The aim of the current study is to present a strategy to improve the efficiency of 5-fluorouracil (5-FU), which is widely used as antineoplastic agent against solid tumors-based on the use of gold nanocarriers to overcome the resistance of colorectal cancer cells. 5-FU was loaded on gold nanoparticles (AuNP) coated with anti-EGFR antibodies in order to target them towards colorectal cancer cells that overexpress epidermal growth factor receptors (EGFR). Physicochemical characterization has shown that AuNP size was approximately 20 nm and that AuNP functionalization led to spherical nanoparticles. Flow cytometry allowed observing that some compounds synthesized by our research group have induced apoptosis/necrosis and impaired the proliferation of colon cancer cell lines ‘HCT-116′ and ‘HT-29′. The antibody/drug combination in AuNP (AuNP 5FU EGFR) has improved the apoptosis rate and impaired cell proliferation in both cell lines, regardless of the exposure time. Overall, these results have shown that AuNP functionalization with monoclonal antibodies focused on delivering 5-FU to tumor cells is an exciting strategy against colorectal cancer.

1 July 2020 in International Immunopharmacology
Verified
Journal Article
Closed access
JRJofer Andree Zamame Ramirez
Jofer Andree Zamame Ramirez
GRGraziela Gorete Romagnoli
Graziela Gorete Romagnoli
BFBianca Francisco Falasco
Bianca Francisco Falasco
CGCarolina Mendonça Gorgulho
Carolina Mendonça Gorgulho
CFCarla Sanzochi Fogolin
Carla Sanzochi Fogolin
RKRamon Kaneno
Ramon Kaneno

1 November 2020 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
ECEdson José Comparetti
Edson José Comparetti
GRGraziela Gorete Romagnoli
Graziela Gorete Romagnoli
CGCarolina Mendonça Gorgulho
Carolina Mendonça Gorgulho
VPValber de Albuquerque Pedrosa
Valber de Albuquerque Pedrosa
RKRamon Kaneno
Ramon Kaneno

4 August 2017 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Open access
PDF file
LSLívia M da Silva
Lívia M da Silva
YFYahima Frión-Herrera
Yahima Frión-Herrera
ABAriane R Bartolomeu
Ariane R Bartolomeu
CGCarolina Mendonça Gorgulho
Carolina Mendonça Gorgulho
JSJosé Maurício Sforcin
José Maurício Sforcin
Objectives: The effects of propolis and phenolic compounds (caffeic acid – Caf; dihydrocinnamic acid – Cin; p-coumaric acid – Cou) in the same quantity found in our propolis sample were investigated on human laryngeal epidermoid carcinoma (HEp-2) cells. Methods: Cell viability, apoptosis/necrosis and cell cycle arrest, P53 and CASPASE-3 gene expression, generation of reactive oxygen species (ROS) and the ability of propolis to induce doxorubicin (DOX) efflux using a P-glycoprotein (P-gp) inhibitor (verapamil) were assayed. Key findings: Propolis exerted a cytotoxic effect on HEp-2 cells, whereas isolated compounds had no effect on cell viability. Higher concentrations were tested and Caf induced late apoptosis or necrosis in HEp-2 cells, while propolis induced apoptosis, both probably due to ROS generation. P53 expression was downregulated by propolis but not by Caf. CASPASE-3 expression was correlated with induction of both early and late apoptosis, with both propolis and Caf alone upregulating its expression. Propolis induced cell cycle arrest at G2/M phase and Caf at S phase. Propolis but not Caf may act as a P-gp inhibitor by modulating P-gp activity and inhibiting DOX efflux. Conclusions: Propolis exerted cytotoxic effects on HEp-2 cells, and the mechanisms are discussed, showing its potential as an antitumour drug.

1 January 2019
Verified
Book Chapter
Closed access
CGCarolina Mendonça Gorgulho
Carolina Mendonça Gorgulho
PMPranav Murthy
Pranav Murthy
LLLance Liotta
Lance Liotta
VEVirginia Espina
Virginia Espina
MLMichael Thomas Lotze
Michael Thomas Lotze